ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 1201 • ACR Convergence 2024

    Association of COVID-19 Vaccinations with Osteoarthritis Flares: A Case-Crossover Study

    Minerva Nong1, Colby Lewis V2, Genna Braverman3, Vivian Bykerk3, Nathaniel Hupert2, Medha Barbhaiya3 and Lisa Mandl3, 1Hospital for Special Surgery, Tampa, FL, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, New York, NY

    Background/Purpose: People with osteoarthritis (OA) commonly experience periods of increased pain and stiffness (“flares”), which can be distressing and disabling. Despite the prevalence of OA…
  • Abstract Number: 1508 • ACR Convergence 2024

    Clinical Characteristics and Prognosis of Late-onset Systemic Lupus Erythematosus in 305 Japanese Patients

    Yuko Shirota1, Misa Oguma2, Ryo Kuwata3, Yumi Tajima4, Yumiko Oka5, Miki Takeshita2, Takao Kodera2 and Tomonori Ishii2, 1Tohoku University Hospital / Department of Hematology and Rheumatology, Sendai, Japan, 2Tohoku Medical and Pharmaceutical University / Department of Hematology and Rheumatology, Sendai, Japan, 3National Center for Global Health and Medicine / Division of Rheumatic Diseases, Shinjyuku, Tokyo, Japan, 4Tohoku Medical and Pharmaceutical University / Department of Hematology and Rheumatology, Sendai, Miyazaki, Japan, 5Tohoku Medical and Pharmaceutical University / Department of Hematology and Rheumatology, Sendai

    Background/Purpose: In recent years, the number of older patients with systemic lupus erythematosus (SLE) in Japan has been increasing, with particular attention to those developing…
  • Abstract Number: 1881 • ACR Convergence 2024

    Cross-State Comparative Assessment of Burden of Rheumatoid Arthritis in the United States and It’s Trend from 1990-2021: A Benchmarking Analysis for the Global Burden of Disease Study 2022

    Rafael Sanchez-Dopazo,1, Eva Kalra2, Shadi Abuhashem3, abobakr Saleh4, Khalid Faris5, Rutvik Raval6, Shamitha Hejmadi6, Lovekumar Vala7, Riya Dhadhal8 and Hardik Desai9, 1Larkin Community Hospital Palm Springs Campus, Hialeah, FL, 2Trident Medical Cente, Charleston, SC, 3Alquds University, Jerusalem, West Bank, Palestine, 9458123, Gaza, Palestinian Territories, 4kasr alainy Medical School - Cairo University,Egypt/ 11956, Cairo, Egypt, 5Studied in Al-Quds university, Palestine, Gaza, Palestinian Territories, 6B.J. Medical College, Ahmedabad, India, 7Department of Internal Medicine, Shantabaa Medical College and General Hospital, Amreli, Gujarat, India, 365601, Amreli, Gujarat, India, 8SMIMER Hospital & Medical College, Surat, Gujarat, India, 9Gujarat Adani Institute of Medical Sciences, Bhuj, India

    Background/Purpose: The burden of Rheumatoid Arthritis (RA) in the United States is considerable, both in terms of its prevalence and the economic costs it incurs.…
  • Abstract Number: 1906 • ACR Convergence 2024

    Bayesian Algorithm to Identify Osteoarthritis in Administrative Health Data Without Requiring Chart Review

    S. Reza Jafarzadeh1, Sarah Tilley1, Anup Arvind1 and David Felson2, 1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 2Boston University, Boston, MA

    Background/Purpose: Osteoarthritis (OA) is the most prevalent arthritis and a significant contributor to Years Lived with Disability. Administrative health data are widely used to study…
  • Abstract Number: 2322 • ACR Convergence 2024

    Predictors of Work Impairment and Absence Amongst People with Psoriatic Arthritis (PsA) – Evidence from the British Society for Rheumatology PsA Register (BSR-PsA)

    Lili Xu1, Gareth Jones1, Ovidiu Rotariu1, Philip S. Helliwell2, Stefan Siebert3, Rosemary Hollick1 and Gary Macfarlane1, 1University of Aberdeen, Aberdeen, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK, Leeds, United Kingdom, 3School of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: People with PsA often report that their condition affects their ability to work. Poor work outcomes, such as work impairment, absence or leaving work,…
  • Abstract Number: 2556 • ACR Convergence 2024

    A Multi-center Study of Associations Between Neighborhood-Level Child Opportunity, Initial Disease Severity and Acute Care Utilization Among Children with SLE

    Joyce Chang1, Jessica Liu1, Emily Smitherman2, Pooja Patel3, Gabrielle Alonzi1, Gabrielle Morgan4, Livie Timmerman5, Laura Berbert6, Edie Weller1, Karen Costenbader7 and Mary Beth Son8, 1Boston Children's Hospital, Boston, MA, 2University of Alabama at Birmingham, Birmingham, AL, 3Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 4Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL, 5University of Alabama at Birmingham, Gardendale, AL, 6Boston Children's Hospital, Belmont, MA, 7Brigham and Women's Hospital/ Harvard Medical School, Boston, MA, 8Boston Children's Hospital, Brookline, MA

    Background/Purpose: Child opportunity is defined as the neighborhood resources and conditions that promote healthy childhood development. We determined whether low neighborhood-level opportunity associates with more…
  • Abstract Number: 0139 • ACR Convergence 2023

    Systemic Vasculitides in Portugal and Brazil: Preliminary Results from the Reuma.pt/vasculitis Registry

    Mariana de Aguiar1, Alexandre wagner Silva de Souza2, Joana Martinho3, Adriana Carones4, Ana Beatriz Bacchiega de Freitas5, Ana Catarina Duarte6, Ana Filipa Águeda7, Camila Souto Oliveira Elias8, Catarina Cortesão9, Catarina Soares10, Carla Macieira11, Carlos Eduardo Garcez Teixeira12, Daniela Peixoto13, Duarte Vinha3, Estela Nogueira3, Fabricia Simil14, Francisca Guimarães13, Frederico Rajão Martins15, Gilda Ferreira16, Helena Assunção4, Heloisa Rulff8, Jorge Pestana Lopes6, José Costa3, Julia Medeiros17, Lilian Santos Porto18, Luiz Felipe Adsuara17, Manuella Ochtrop8, Maria João Gonçalves19, Mariana Diz Lopes20, Matheus Vieira21, Nikita Khmelinskii11, Rita Torres22, Sarah Neaime1, Vitor Teixeira23, Zoraida Sachetto12 and Cristina Ponte24, 1Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil, 2Division of Rheumatology, Medical School, Universidade Federal de São Paulo, São Paulo, Brazil, 3Centro Hospitalar Universitario Lisboa Norte, Lisboa, Portugal, 4Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, 5Faculdade de Ciências da Saúde de Barretos, Barretos, Brazil, 6Hospital Garcia de Orta, Almada, Portugal, 7Centro Hospitalar Universitário Cova da Beira, Covilhã, Portugal, 8Universidade Estadual do Rio de Janeiro, Rio de Janeiro, Brazil, 9Instituto Português de Reumatologia, Lisboa, Portugal, 10Centro Unidade Local de Saúde do Alto Minho, Viana do Castelo, Portugal, 11Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 12Universidade Estadual de Campinas, Campinas, Brazil, 13Centro Unidade Local de Saúde do Alto Minho, Ponte de Lima, Portugal, 14Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 15Department of Rheumatology, University Hospital Centre of Algarve, Faro, Portugal, 16Federal University of Minas Gerais, Belo Horizonte, Brazil, 17Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil, 18Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Brazil, 19Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal, 20Centro Hospitalar Universitário de São João, Porto, Portugal, 21Universidade Federal de São Paulo; Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 22Hospital Egas Moniz, Lisboa, Portugal, 23Hospital de Faro, CHUA, Lisbon, Portugal, 24Department of Rheumatology, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal

    Background/Purpose: The epidemiology of vasculitis varies widely across different geographic areas of the world which may be due to different ethnic and environmental factors. Brazil…
  • Abstract Number: 0477 • ACR Convergence 2023

    Continuing TNFi After Pregnancy Diagnosis in Women with Chronic Rheumatic Inflammatory Diseases Is Not Associated with Worse Obstetrical or Infant Outcomes and Seems to Reduce Risk of Maternal Severe Infection: The Results of the Emulated Target Trial BioGRIC

    Anna Molto1, aya ajrouche2, Diep Tran2, Nathalie Costedoat-Chalumeau3, Elisabeth Elefant4, Vassilis Tsatsaris5, Jeanne Fresson6, Brigitte Bader-Meunier5, Bruno Fautrel7 and Florence Tubach2, 1HOPITAL COCHIN AP-HP, Service de Rhumatologie, Paris, France, 2Centre de pharmaco-épidémiologie de l'APHP, Paris, France, 3Inserm DR Paris 5, Paris, France, 4APHP, Paris, France, 5Paris-Cité University, Paris, France, 6CHU Nancy, Nancy, France, 7Sorbonne Université APHP, Paris, France

    Background/Purpose: Many women with chronic rheumatic inflammatory diseases (CRID) stop tumor necrosis factor inhibitors (TNFi) treatment once pregnancy is confirmed to avoid potential adverse fetal…
  • Abstract Number: 0739 • ACR Convergence 2023

    Major Adverse Cardiovascular Event and Venous Thromboembolism Risk Comparing Advanced Therapies Among Individuals with Axial Spondylarthritis and Psoriatic Arthritis

    Sali Merjanah1, Devin Driscoll2, Christine Peloquin3, Jean liew3 and Maureen Dubreuil4, 1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 2Boston University/Boston Medical Center, Boston, MA, 3Boston University, Boston, MA, 4Department of Rheumatology, Boston University School of Medicine, Milton, MA

    Background/Purpose: Individuals with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) have increased cardiovascular risk compared to the general population, which is partly explained by systemic…
  • Abstract Number: 0985 • ACR Convergence 2023

    Assessing the Value of Comorbidity Clusters in Predicting Clinical Outcomes in Rheumatoid Arthritis: A Machine Learning Approach Using a Very Large US Registry

    Daniel Solomon1, Fredrik Johansson2, Hongshu Guan3, Leah Santacroce4, Lin Guo5, Wendi Malley5 and Heather Litman5, 1Brigham and Women's Hospital, Newton, MA, 2Chalmers University of Technology, Goteborg, Sweden, 3Brigham and Women's Hospital, Boston, MA, 4Brigham and Women's Hospital, Boston, MA, 5CorEvitas, LLC, Waltham, MA

    Background/Purpose: Comorbid conditions are very common in rheumatoid arthritis (RA) and several prior studies have derived comorbidity clusters using machine learning (ML). Clustering using ML…
  • Abstract Number: 1352 • ACR Convergence 2023

    Similar Delivery Outcomes in Pregnant Patients with and Without Takayasu Arteritis – A Nationwide Inpatient Database Study

    Yanint Raksadawan1, Aravind Polam1, Nattanicha Chaisrimaneepan2 and Sabahat Usmani1, 1Weiss Memorial Hospital, Chicago, IL, 2Texas Tech University Health Sciences, Lubbock, TX

    Background/Purpose: Takayasu's arteritis (TA) is a large vessel vasculitis which affects women of reproductive age. There is limited information about the effect of TA on…
  • Abstract Number: 1806 • ACR Convergence 2023

    The Prevalence of Cardiac Sarcoidosis – A Systemic Review and Meta-Analysis

    Daming Shao1, Jiyoung Seo1, Shaunak Mangeshkar1, Natalia Nazarenko1, Stepan Esagian1, Leonidas Palaiodimos1 and Damianos Kokkinidis2, 1Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY, 2Yale University School of Medicine, New Haven, CT

    Background/Purpose: Cardiac sarcoidosis (CS) results from granulomatous infiltrating of the myocardium and manifests as an extended clinical spectrum from silence to conduction disturbances, ventricular tachyarrhythmias,…
  • Abstract Number: 1979 • ACR Convergence 2023

    Weight Loss Induced by Anti-obesity Medications and All-cause Mortality Among Patients with Knee or Hip Osteoarthritis

    Jie Wei1, david Hunter2, Nancy Lane3, Jing Wu4, Chao Zeng5, Guanghua Lei5 and Yuqing Zhang6, 1Health Management Center, Xiangya Hospital Central South University, Changsha, China, 2Sydney Musculoskeletal Health, University of Sydney, St. Leonards, Australia, 3University of California, Hillsborough, CA, 4Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, China, 5Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China, 6Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA

    Background/Purpose: The current international guidelines recommend weight loss for pain relief and functional improvement in overweight or obese patients with knee or hip osteoarthritis; however,…
  • Abstract Number: 2281 • ACR Convergence 2023

    Epidemiology and Risk of Brain Abscess in Patients with Systemic Lupus Erythematosus in Taiwan: A Nationwide Population-based Study

    Ke-Hung Lin1, Tzu-Min Lin1 and Chi-Ching Chang2, 1Taipei Medical University Hospital, Taipei, Taiwan, 2Taipei Medical University, Taipei, Taiwan

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune systemic disorder with high morbidity and mortality. Although CNS infections account for only 0.53–2.25% of all infections…
  • Abstract Number: 2531 • ACR Convergence 2023

    Proton Pump Inhibitor Use Is Associated with Impaired Bone Mineral Density but Not Bone Microarchitecture in Patients with Inflammatory Rheumatic and Musculoskeletal Diseases Taking Glucocorticoids

    Andriko Palmowski1, Gabriela Schmajuk2, Jinoos Yazdany3, Patti Katz4, Jing Li5, Rachael Stovall5, Emma Kersey5, Sabrina Mai Nielsen6, Robin Christensen7, Henning Bliddal8, Zhivana Boyadzhieva9, Udo Schneider9, Tobias Alexander10, Burkhard Muche11, Sandra Hermann11, Edgar Wiebe11 and Frank Buttgereit11, 1Charité - Universitätsmedizin Berlin, Berlin, Germany, 2UCSF / SFVA, San Francisco, CA, 3University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA, 4University of California San Francisco, San Rafael, CA, 5University of California San Francisco, San Francisco, CA, 6The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, 7Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen, Denmark, 8The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark, 9Charité Universitatsmedizine - Berlin, Berlin, Germany, 10Charité Universiätsmedizin Berlin, Dept. Rheumatology, Berlin, Germany, 11Charité Universitätsmedizin, Dept. Rheumatology, Berlin, Germany

    Background/Purpose: Patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs) are at increased risk of osteoporosis and fragility fractures. For this population, whether proton pump inhibitor…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 55
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology